Literature DB >> 10525267

Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase.

S Lin1, W R Cullen, D J Thomas.   

Abstract

Thioredoxin reductase (TR, EC 1.6.4.5) was purified 5800-fold from the livers of adult male B6C3F1 mice. The estimated molecular mass of the purified protein was about 57 kDa. The activity of the purified enzyme was monitored by the NADPH-dependent reduction of 5, 5'-dithiobis(2-nitrobenzoic acid) (DTNB); this activity was fully inhibited by 1 microM aurothioglucose. Arsenicals and arsinothiols, complexes of As(III)-containing compounds with L-cysteine or glutathione, were tested as inhibitors of the DTNB reductase activity of the purified enzyme. Pentavalent arsenicals were much less potent inhibitors than trivalent arsenicals. Among all the arsenicals, CH(3)As(III) was the most potent inhibitor of TR. CH(3)As(III) was found to be a competitive inhibitor of the reduction of DTNB (K(i) approximately 100 nM) and a noncompetitive inhibitor of the oxidation of NADPH. The inhibition of TR by CH(3)As(III) was time-dependent and could not be reversed by the addition of a dithiol-containing molecule, 2,3-dimercaptosuccinic acid, to the reaction mixture. The inhibition of TR by CH(3)As(III) required the simultaneous presence of NADPH in the reaction mixture. However, unlike other pyridine nucleotide disulfide oxidoreductases, there was no evidence that mouse liver TR was inactivated by exposure to NADPH. Treatment with CH(3)As(III) did not increase the NADPH oxidase activity of the purified enzyme. Thus, CH(3)As(III), a putative intermediate in the pathway for the biomethylation of As, is a potent and irreversible inhibitor of an enzyme involved in the response of the cell to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525267     DOI: 10.1021/tx9900775

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  38 in total

1.  Using mathematical modeling to infer the valence state of arsenicals in tissues: A PBPK model for dimethylarsinic acid (DMAV) and dimethylarsinous acid (DMAIII) in mice.

Authors:  Lydia M Bilinsky; David J Thomas; Jeffrey W Fisher
Journal:  J Theor Biol       Date:  2018-10-26       Impact factor: 2.691

2.  Combined ion-mobility and mass-spectrometry investigations of metallothionein complexes using a tandem mass spectrometer with a segmented second quadrupole.

Authors:  Yuzhu Guo; Yun Ling; Bruce A Thomson; K W Michael Siu
Journal:  J Am Soc Mass Spectrom       Date:  2005-09-22       Impact factor: 3.109

3.  Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism.

Authors:  Kristin E Porter; Anamika Basu; Alan E Hubbard; Michael N Bates; David Kalman; Omar Rey; Allan Smith; Martyn T Smith; Craig Steinmaus; Christine F Skibola
Journal:  Environ Res       Date:  2010-06-01       Impact factor: 6.498

4.  Monomethylarsonous acid induces transformation of human bladder cells.

Authors:  Tiffany G Bredfeldt; Bhumasamudram Jagadish; Kylee E Eblin; Eugene A Mash; A Jay Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-27       Impact factor: 4.219

5.  Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).

Authors:  Zhiguo Li; Ying Lu; Nihal Ahmad; Klaus Strebhardt; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Distinct signaling pathways respond to arsenite and reactive oxygen species in Schizosaccharomyces pombe.

Authors:  Miguel A Rodríguez-Gabriel; Paul Russell
Journal:  Eukaryot Cell       Date:  2005-08

7.  Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage.

Authors:  Mayukh Banerjee; Nilanjana Banerjee; Pritha Ghosh; Jayanta K Das; Santanu Basu; Ajoy K Sarkar; J Christopher States; Ashok K Giri
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-20       Impact factor: 4.219

Review 8.  A review of toxicity and mechanisms of individual and mixtures of heavy metals in the environment.

Authors:  Xiangyang Wu; Samuel J Cobbina; Guanghua Mao; Hai Xu; Zhen Zhang; Liuqing Yang
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-11       Impact factor: 4.223

9.  Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.

Authors:  S Talbot; R Nelson; W T Self
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  Exposure to monomethylarsonous acid (MMA(III)) leads to altered selenoprotein synthesis in a primary human lung cell model.

Authors:  Sarah R Meno; Rebecca Nelson; Korry J Hintze; William T Self
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-27       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.